Anne Michel

1.3k citations

20 papers · 848 indexed · h-index 15

Impact in

Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Neuroinflammation and Neurodegeneration Mechanisms
Cellular and Molecular Neuroscience top 5%
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
- Nerve injury and regeneration

Papers in

Cellular and Molecular Neuroscience 14
- Neuroscience and Neuropharmacology Research 12
- Neurotransmitter Receptor Influence on Behavior 6
Neurology 10
- Parkinson's Disease Mechanisms and Treatments 9
- Neurological disorders and treatments 8
- Neuroinflammation and Neurodegeneration Mechanisms 2

Co-authors: Patricia García‐Sanz Mireille Dumoulin Noelia Granado Rosario Moratalla Ezio Tirelli Alan R. Crossman R. Grimée Henrik Klitgaard
Journals: Behavioural Brain Research (3 papers)PLoS ONE (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Clinical Neuropharmacology (1 paper)Behavioural Pharmacology (1 paper)
Partner nations: Belgium France United Kingdom

In The Last Decade

Anne Michel

20 papers receiving 835 citations

Peers

Countries citing papers authored by Anne Michel

Since Specialization

Citations

This map shows the geographic impact of Anne Michel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Michel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Michel more than expected).

Fields of papers citing papers by Anne Michel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Michel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Michel. The network helps show where Anne Michel may publish in the future.

Co-authors

The 25 scholars most cited alongside Anne Michel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anne Michel Line = papers co-authored together Anne Michel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Monitoring of a progressive functional dopaminergic deficit in the A53T-AAV synuclein rats by combining 6-[18F]fluoro-L-m-tyrosine imaging and motor performances analysis Neurobiology of Aging ·Guillaume Becker, Anne Michel, Mohamed Ali Bahri, Georges Mairet‐Coello, Christian Lemaire, Matthew P. Abdel, N. Bakri, C. Garcia-Duarte, S. Sándor, Catherine De Wolf, 裕二藤本, Yolanda Rachel Mediarsari Beru Barus, 尹艳霞, Erwan Bézard, Gaëtan Garraux, André Luxen, Martin Citron, Patrick Downey, Alain Plenevaux	2021	5
2	Modeling Parkinson’s Disease With the Alpha-Synuclein Protein Frontiers in Pharmacology ·O. B. Loginova, Noelia Granado, Patricia García‐Sanz, Anne Michel, Mireille Dumoulin, Rosario Moratalla	2020	278
3	Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody Brain ·Esteban Jove, Georges Mairet‐Coello, Clément Danis, А. В. Чашков, Raphaëlle Caillierez, Sébastien Carrier, Jessica Gartrell, Isabelle Landrieu, Anne Michel, Mathieu Schmitt, Martin Citron, Patrick Downey, Jean‐Philippe Courade, Luc Buée, Morvane Colin	2019	127
4	G-Protein-Coupled Receptor Gpr17 Expression in Two Multiple Sclerosis Remyelination Models Molecular Neurobiology ·Stella Nyamoya, Sebastian Dorywalski, E. Hatta, Cordian Beyer, S. Sándor, Christoph Schmitz, Anne Michel, Markus Kipp	2018	31
5	Antiparkinsonian effects of the "Radiprodil and Tozadenant" combination in MPTP-treated marmosets PLoS ONE ·Anne Michel, Uğur TEKİN, Sarah Rose, Michael S. Jackson, Peter Colman, P K Mittal Smriti, David Sciberras, Pierandrea Muglia, D. Scheller, Martin Citron, Patrick Downey	2017	13
6	A Machine Learning Approach to Automated Gait Analysis for the Noldus Catwalk System IEEE Transactions on Biomedical Engineering ·Holger Fröhlich, Kasper Claes, Catherine De Wolf, Ahmet Murat Alper, Anne Michel	2017	27
7	Comparative assessment of 6‐[¹⁸F]fluoro‐L‐m‐tyrosine and 6‐[¹⁸F]fluoro‐L‐dopa to evaluate dopaminergic presynaptic integrity in a Parkinson's disease rat model Journal of Neurochemistry ·Guillaume Becker, Mohamed Ali Bahri, Anne Michel, S. Sándor, Gaëtan Garraux, André Luxen, Christian Lemaire, Alain Plenevaux	2017	14
8	In Vitro and In Vivo Identification of Novel Positive Allosteric Modulators of the Human Dopamine D2 and D3 Receptor Molecular Pharmacology ·Martyn Wood, P. Mcclelland, Véronique André, Anne Michel, Robert J. Barnaby, Michel Gillard	2015	20
9	Alpha synuclein dimers and oligomers are increased in overexpressing conditions in vitro and in vivo Molecular and Cellular Neuroscience ·Daniele Marmolino, Patrik Foerch, Franck Atienzar, Ludovicus Staelens, Anne Michel, D. Scheller	2015	17
10	Behavioural Assessment of the A2a/NR2B Combination in the Unilateral 6-OHDA-Lesioned Rat Model: A New Method to Examine the Therapeutic Potential of Non-Dopaminergic Drugs PLoS ONE ·Anne Michel, Patrick Downey, Ahmet Murat Alper, Catherine De Wolf, Rainer K.W. Schwarting, D. Scheller	2015	16
11	Unprecedented Therapeutic Potential with a Combination of A2A/NR2B Receptor Antagonists as Observed in the 6-OHDA Lesioned Rat Model of Parkinson's Disease PLoS ONE ·Anne Michel, Patrick Downey, Jean‐Marie Nicolas, D. Scheller	2014	19
12	Behavioural phenotyping reveals anxiety-like features of SV2A deficient mice Behavioural Brain Research ·Yves Lamberty, Eric Detrait, Karine Leclercq, Anne Michel, Marc De Ryck	2008	11
13	Levetiracetam Interferes With the l-Dopa Priming Process in MPTP-Lesioned Drug-Naive Marmosets Clinical Neuropharmacology ·Michael P. Hill, Jonathan M. Brotchie, Alan R. Crossman, Erwan Bézard, Anne Michel, R. Grimée, Henrik Klitgaard	2004	21
14	Levetiracetam Potentiates the Antidyskinetic Action of Amantadine in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease Journal of Pharmacology and Experimental Therapeutics ·Michael P. Hill, Paula Ravenscroft, Erwan Bézard, Alan R. Crossman, Jonathan M. Brotchie, Anne Michel, R. Grimée, Henrik Klitgaard	2004	66
15	Levetiracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque European Journal of Pharmacology ·Erwan Bézard, Michael P. Hill, Alan R. Crossman, Jonathan M. Brotchie, Anne Michel, R. Grimée, Henrik Klitgaard	2004	58
16	Levetiracetam (keppra) potentiates the anti-dyskinetic action of amantadine in the MPTP-lesioned marmoset model of Parkinson's disease Journal of Pharmacology and Experimental Therapeutics ·村松淳司, Jonathan M. Brotchie, Anne Michel, Erwan Bézard, Martin Hill, Paula Ravenscroft, R. Grimée, Título da Tese	2003	1
17	The magnitude and the extinction duration of the cocaine-induced conditioned locomotion-activated response are related to the number of cocaine injections paired with the testing context in C57BL/6J mice Behavioural Brain Research ·Anne Michel, Sophie Tambour, Ezio Tirelli	2003	24
18	Conditioned hyperkinesia induced by cocaine in mice is dose-dependent but not correlated with the unconditioned response or the contextually-sensitized response Behavioural Pharmacology ·Anne Michel, Ezio Tirelli	2002	17
19	Post-sensitisation conditioned hyperlocomotion induced by cocaine is augmented as a function of dose in C57BL/6J mice Behavioural Brain Research ·Anne Michel, Ezio Tirelli	2002	12
20	Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice Neuropharmacology ·Roney César Signorini Filho, Anne Michel, Diana Montgomery, R.L. Whiting	1989	71

About Anne Michel

Anne Michel is a scholar working on Cellular and Molecular Neuroscience, Neurology, Developmental Biology, Neurology and Developmental Neuroscience, having authored 20 papers that have together received 848 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (12 papers), Parkinson's Disease Mechanisms and Treatments (9 papers), Neurological disorders and treatments (8 papers), Neurotransmitter Receptor Influence on Behavior (6 papers), Memory and Neural Mechanisms (3 papers), Epilepsy research and treatment (2 papers), Neurological and metabolic disorders (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). The work is most often cited by research in Neurology (365 citations), Cellular and Molecular Neuroscience (378 citations), Neurology (116 citations), Behavioral Neuroscience (28 citations) and Physiology (190 citations). Anne Michel has collaborated with scholars based in Belgium, France and United Kingdom. Frequent co-authors include Patricia García‐Sanz, Mireille Dumoulin, Noelia Granado, Rosario Moratalla, Ezio Tirelli, Alan R. Crossman, R. Grimée, Henrik Klitgaard, Erwan Bézard and Jonathan M. Brotchie. Their work appears in journals such as Behavioural Brain Research, PLoS ONE, Journal of Pharmacology and Experimental Therapeutics, Clinical Neuropharmacology and Behavioural Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact